Insider · CIK 0001419066
Elizabeth A Olek
Files at KRON (Kronos Bio, Inc.). First filing Feb 23, 2024, latest Feb 23, 2024.
In brief
Elizabeth A Olek files SEC Form 4 as officer at KRON (Kronos Bio, Inc.). Since Feb 23, 2024, Elizabeth A Olek has reported 0 open-market buys worth $0 and 1 open-market sell worth $7,765, the latest filed on Feb 23, 2024.
A track record needs three past buys with six months of prices behind them; Elizabeth A Olek has 0, so none is measured yet.
The newest scored trade: sold $7,765 of KRON on Feb 21, 2024, filed Feb 23, 2024, scored 30 (weak).
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | KRON Kronos Bio, Inc. | SOpen-market sale Common Stock | -7,368 | $1.05 | $7,765 | 193,275 | Feb 23, 2024 |
Questions about Elizabeth A Olek
Answered from the filings on this page, as of the latest one.
Is Elizabeth A Olek buying or selling?
Not in the last 12 months. Elizabeth A Olek's latest open-market trade on SEC Form 4 was sold $7,765 of KRON on Feb 21, 2024.
How did Elizabeth A Olek's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Elizabeth A Olek has 0.
Where does Elizabeth A Olek file Form 4?
Elizabeth A Olek has filed Form 4 at KRON (Kronos Bio, Inc.) as SR VP, CLINICAL SCIENCE. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.